GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Innovation1 Biotech Inc (OTCPK:IVBT) » Definitions » Price-to-Free-Cash-Flow

Innovation1 Biotech (Innovation1 Biotech) Price-to-Free-Cash-Flow : N/A (As of Jun. 06, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Innovation1 Biotech Price-to-Free-Cash-Flow?

As of today (2024-06-06), Innovation1 Biotech's share price is $0.0008. Innovation1 Biotech's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Aug. 2023 was $-0.03. Hence, Innovation1 Biotech's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Innovation1 Biotech's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 9 years, Innovation1 Biotech's highest Price-to-Free-Cash-Flow Ratio was 31.76. The lowest was 6.46. And the median was 19.61.

IVBT's Price-to-Free-Cash-Flow is not ranked *
in the Diversified Financial Services industry.
Industry Median: 36.98
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Innovation1 Biotech's Free Cash Flow per Share for the three months ended in Aug. 2023 was $-0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-0.03.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 71.70% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 53.10% per year.

During the past 9 years, Innovation1 Biotech's highest 3-Year average Free Cash Flow per Share Growth Rate was 71.70% per year. The lowest was -502.90% per year. And the median was -6.65% per year.


Innovation1 Biotech Price-to-Free-Cash-Flow Historical Data

The historical data trend for Innovation1 Biotech's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovation1 Biotech Price-to-Free-Cash-Flow Chart

Innovation1 Biotech Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only - - - - -

Innovation1 Biotech Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Innovation1 Biotech's Price-to-Free-Cash-Flow

For the Shell Companies subindustry, Innovation1 Biotech's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innovation1 Biotech's Price-to-Free-Cash-Flow Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Innovation1 Biotech's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Innovation1 Biotech's Price-to-Free-Cash-Flow falls into.



Innovation1 Biotech Price-to-Free-Cash-Flow Calculation

Innovation1 Biotech's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.0008/-0.03
=N/A

Innovation1 Biotech's Share Price of today is $0.0008.
Innovation1 Biotech's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Innovation1 Biotech  (OTCPK:IVBT) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Innovation1 Biotech Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Innovation1 Biotech's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Innovation1 Biotech (Innovation1 Biotech) Business Description

Traded in Other Exchanges
N/A
Address
40 Wall Street, Suite 2701, New York, NY, USA, 10005
Innovation1 Biotech Inc is a shell company.
Executives
Grays Peak Llc 10 percent owner 8 THE GREEN, STE. A, DOVER DE 19803
Timothy Orr director, 10 percent owner, officer: President 4010 TANAGER LANE, #A, MEAD WA 99021
Darren Long director, 10 percent owner, officer: CEO & Secretary 4010 TANAGER LANE, #A, MEAD WA 99021
Brian Martinho director, 10 percent owner, officer: Treasurer 4010 EAST TANAGER LANE, MEAD WA 99021